NRG-GU014: Randomized Phase II Trial of Pembrolizumab and Radiation vs Radiation and Concurrent Chemotherapy for High-Grade T1 Bladder Cancer (PARRC)
- Title
- Randomized Phase II Trial of Pembrolizumab and Radiation vs Radiation and Concurrent Chemotherapy for High-Grade T1 Bladder Cancer (PARRC)
- Principal Investigator
- Kolodney, Joanna
- Phase
- II
- Age Group
- Adult
- Applicable Disease Sites
- Genitourinary Cancers
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts
- Jill Stone, LPN
- Research Specialist
- Phone: +1 304-634-4417
- Email: jill.stone@hsc.wvu.edu